Concepedia

Elizabeth R. Glaze

ER

Statistics

Publications

7

Citations

322

H-Index

7

Active since

2004

Affiliations

National Cancer Institute(Current)

Southern Research Institute

IIT Research Institute

University of Illinois Chicago

UPMC Hillman Cancer Center

Elizabeth R. Glaze is an author at National Cancer Institute specializing in pharmacology, pharmacokinetics, and drug disposition.

Publications per year

2004–2016

7

Publications

7

Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance

Elizabeth R. Glaze, Amy L. Lambert, Adaline C. Smith et al. · Cancer Chemotherapy and Pharmacology · 2005 · 116 citations

, , +9

Plasma Pharmacokinetics, Oral Bioavailability, and Interspecies Scaling of the DNA Methyltransferase Inhibitor, Zebularine

Julianne L. Holleran, Robert A. Parise, Erin Joseph et al. · Clinical Cancer Research · 2005 · 96 citations

, , +17

A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.

Elizabeth R. Glaze, Michael J. Roy, Lonnie W Dalrymple et al. · PubMed · 2015 · 34 citations · Full text

, , +16

Simultaneous estimation of pharmacokinetic properties in mice of three anti-tubercular ethambutol analogs obtained from combinatorial lead optimization

Lee Jia, Joseph E. Tomaszewski, Patricia E. Noker et al. · Journal of Pharmaceutical and Biomedical Analysis · 2004 · 33 citations

, , +17

Preformulation and pharmacokinetic studies on antalarmin: A novel stress inhibitor

Ritesh Sanghvi, Erik Mogalian, Stephen G. Machatha et al. · Journal of Pharmaceutical Sciences · 2008 · 18 citations

, , +6

1–5 of 7